News und Analysen
3 Reasons to Buy the Dip With Exelixis
In just two days, Exelixis (NASDAQ: EXEL) has lost over 15% of its market cap. The tumble for the once-hot biotech stock started last week with a downgrade of the stock by an analyst at Leerink....
3 Warren Buffett Stocks for Retirees
Warren Buffett is arguably the most revered investor on the planet. Over the course of more than six decades he's turned less than $10,000 into a net worth of nearly $79 billion. What's truly....
AbbVie's Unfazed by the Risk of Generic Humira
Over 60% of AbbVie Inc.’s (NYSE: ABBV) sales come from demand for Humira -- an autoimmune-disease drug prescribed to patients with a variety of conditions -- that racks up sales of $16 billion per....
Better Buy: Kimberly-Clark Corp. vs. Johnson & Johnson
There aren't many companies that can grow sales and profits through a wide range of market conditions. But both Kimberly-Clark (NYSE: KMB), the consumer goods specialist, and Johnson & Johnson....
Oddly, Juno Therapeutics Is Jumping 11.3% Today
Despite a 6.1 million-share follow-on public stock offering, shares of Juno Therapeutics (NASDAQ: JUNO) are rallying 11.3% higher at 3 p.m. EDT.Juno Therapeutics shares have been rallying since....
This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%
Shares of biopharma Versartis (NASDAQ: VSAR) crashed nearly 87% Friday after somavaratan, the company's lead drug candidate, did not meet its primary endpoint in the phase 3 Velocity trial. The....
AstraZeneca Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Last week, Gilead Sciences (NASDAQ: GILD) announced that it was borrowing $3 billion. That's billion with a "B."The company doesn't really need the money. It was sitting on $36.6 billion in cash,....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
You expect a top-ranked football team to play well every game. You expect the Kentucky Derby winner to place in the Preakness Stakes. And you expect a stock with a high valuation to generate....
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ: CELG) and Merck & Co. (NYSE: MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% over the past five....
3 Stocks to Help You Make Money in Retirement
Especially if you're looking forward to a long retirement, you'll still want to own some stocks after you've cashed your final paycheck. Unlike cash or many bonds these days, returns from stocks....
3 Small-Cap Biotech Stocks to Buy This Fall
Hundreds of small-cap biotech stocks are available for investors. All of them come with relatively high levels of risk. With that high risk, though, also comes the potential for high returns.But....
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE: PFE) took direct aim at Johnson & Johnson (NYSE: JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion dollar per year....
Here's Why Quidel Corporation Stock Is Popping Today
Shares of Quidel Corporation (NASDAQ: QDEL), a molecular diagnostics specialist with a focus on quick turnarounds, ticked up 9.3% as of 11:26 a.m. EDT on Tuesday in response to a positive....
3 Innovation-Forward Healthcare Stocks to Buy Now
Illumina (NASDAQ: ILMN), Mazor Robotics (NASDAQ: MZOR), and Novocure (NASDAQ: NVCR) are reshaping healthcare with innovative solutions that may produce market-beating returns for investors. Here's....
3 High-Yield Pharmaceutical Stocks
It can be tempting to buy stocks based solely on their dividend yield, but that can actually be a big mistake. However, that doesn't mean that all high-yield stocks should be avoided.So which big....
Why Bellicum Pharmaceuticals Stock Is Rising Today
Bellicum Pharmaceuticals (NASDAQ: BLCM), a clinical-stage biotech, saw its shares rise in excess of 11% today on almost three times the normal volume. The adoptive cell therapy company's stock....
3 High-Yield Healthcare Stocks
One downside to a long-lasting bull market is that the market's dividend yield declines. That's a big problem for retirees who rely on their portfolio to meet their income needs.Even in today's....
3 Value Stocks for Smart Investors
Value investors know that getting a good stock at a good price can be difficult, particularly in markets like we face to day, but it's always worth it when you find one. They tend to offer the....
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017
There is perhaps no scarier word in the English language than "cancer." More than 15.5 million Americans who were alive as of Jan. 1, 2016, have had cancer at some point in their lives, according....
3 Stocks to Hold for the Next Century
"Buy and hold" sounds like a simple investing strategy, but it only works if you're confident in your stocks for the very long haul. Titans topple all the time, and truly secular investments are....
Don't Make This Huge Mistake With Celgene
Several years ago, I started to look seriously at investing in Celgene (NASDAQ: CELG) stock. Someone I knew told me that I probably shouldn't get too excited about the biotech. I'm glad I didn't....
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Johnson & Johnson (NYSE: JNJ) reported anemic overall sales growth in the first half of 2017. The big healthcare company even saw a decline in year-over-year earnings during the period.....
Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb
You can call them "frenemies." Pfizer (NYSE: PFE) and Bristol-Myers Squibb (NYSE: BMY) are friends when it comes to blockbuster blood thinner Eliquis. But the two big pharma companies are enemies....
3 Stocks to Buy and Hold for Decades
Trading in and out of stocks may be exciting, but it's no way to build wealth. Buying shares of high-quality companies and holding on for the long haul is a far better alternative.We asked three....